Startups
LIXA is focused on developing scalable antibiofilm technologies to treat antimicrobial resistance (AMR), for anyone, anything and anywhere. Our technologies disrupt both mature and immature biofilms and are compatible with most existing antimicrobials. We are open to partnerships to develop real solutions to AMR.
Overview
Location
Australia, Western Australia
Employees
1-10
Total raised
$1.48M
Founded date
2021
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Lixa
When was Lixa founded?
Lixa was founded in 2021.
How much funding has Lixa raised?
Lixa has raised $1.48M in total across 1 funding round.
Is Lixa still active?
Yes, Lixa is active; its latest activity on Parsers VC dates from Jul 10, 2026.